If you are new to using PharmiWeb.com in your job searching, you'll soon realise that we have thousands of jobs listed and that they change every day. This means you may initially find the task a bit daunting.
- Respiratory illness effects more than 1 billion people.
- Asthma is on the increase
- Respiratory drugs generated a total revenue of more than $30.5 billion for the 12 months of 2006
- The market shows a percentage increase year-on-year
Parkinson's is a progressive neurological condition affecting movements such as walking, talking, and writing. It is named after Dr. James Parkinson (1755-1824), the London doctor who first identified Parkinson's as a specific condition.
Parkinson's Disease Society
Nearly six million people in the UK suffer from migraines with 190,000 attacks occurring every day*. Two out of three sufferers are women** and, in total, migraines cost the UK around Ă‚ÂŁ1 billion per annum***.
A child born in a Glasgow, Scotland suburb can expect a life 28 years shorter than another living only 13 kilometers away. A girl in Lesotho is likely to live 42 years less than another in Japan. In Sweden, the risk of a woman dying during pregnancy and childbirth is 1 in 17,400; in Afghanistan, the odds are 1 in 8.
Whether you are looking for pharma sales jobs, clinical research jobs, or any other pharmaceutical job, with thousands of jobs in the PharmiWeb.com database you can be forgiven for not coming back every day to search... Well, you actually dont have to - we can do the searching for you!
The UK government have told kidney cancer patients that new drugs cannot be offered on the National Health Service. Roche's Avastin, Bayer's Nexavar, Pfizer's Sutent and Wyeth's Torisel were not cost-effective. The drugs known generically as bevacizumab, sorafenib, sunitinib and temsirolimus should therefore not be a treatment option for advanced and/or metastatic kidney cancer, NICE said.
The global clinical trials business is worth an estimated $50bn in 2008, with a rate of growth of 10%. In recent years, the nature of clinical trials has changed considerably. An increased emphasis has been placed on cost-effectiveness of pharmaceutical R&D, as well as increased productivity to maintain the high output of recent years.
Arthritis is not just a disease of older people â€“ it can affect people of all ages, including children. It is not clear what causes arthritis and there is no cure at present. However, there is plenty you can do to manage yourcondition and lead a full and active life.
In recent years Negative Pressure Wound Therapy has revolutionised the way clinicians manage and treat a wide range of wounds, Negative Pressure Wound Therapy (NPWT) is a mechanical wound care treatment that uses controlled negative pressure to assist and accelerate wound healing (Bryant, R. 2000).
Cimzia (certolizumab pegol) is the first and so far, only, PEGylated, Fc-Free, anti-tumour necrosis factor (TNF) alpha treatment in development for rheumatoid arthritis. Data presented at the Annual European Rheumatology Congress (EULAR) suggest that, in combination with methotrexate, Cimzia acts fast to significantly suppress disease activity, prevent structural damage to joints, preserve physical function and help patients continue working productively.
Olwen Glynn Owen - Pharmiweb Field reporter
Alzheimer disease (AD) is the third leading cause of death in recent times and with an unprecedented patient potential, this disease area attracts awareness from a broad base of stake holders. With the grey population being the single most influencial factor in driving the economic growth within this sector, Visiongain believes the real market of the AD industry still remains untapped.
A trip to the doctor is the start of a conversation that provides the link between our everyday lives and the medical profession. Each day in the UK more than a million conversations take place between doctors and patients. When governments, policy makers and others talk about healthcare, these conversations often fade into the background. But conversations are the foundation for our health, with enormous potential impact.
It is estimated that one in two smokers will die from a smoking related disease, causing, on average, six to eight years of life lost per smoker. Smokers can also impact the health of those around them, for example their children, through passive smoking.
In 2007, blood diseases cost the USâ€™s economy $114bn. In 2004, a reported 232,000 deaths in the US were due to anaemia, myeloproliferative and myelodysplastic disorders, bleeding disorders, white blood cell disorders and thrombosis collectively. From oxygen delivery to immunological defence to clotting, blood has vital physiological functions, and clear, expensive treatments.
â€śBy 2010, almost 50 percent of children in North America and 38 percent of those in the European Union will be overweight, research has foundâ€ť. For pharmaceutical companies looking to target growing successful markets, the anti-obesity drug treatment market offers unique opportunities.
Nini Wei- Visiongain Ltd
Obesity is the heavy accumulation of fat in your body to such a degree that it rapidly increases your risk of diseases that can damage your health and knock years off your life, such as heart disease and diabetes.
Despite the pressures, medical and healthcare businesses appear to be reacting bullishly to the credit crunch according to a new study released today. When asked if they had to start their business again in todayâ€™s economic climate, 78% of medical and healthcare businesses would do it all again tomorrow.
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her